Dividend6 Aug 2026, 01:01 pm
SMS Pharma Recommends ₹0.40 Dividend for FY26
AI Summary
SMS Pharmaceuticals Ltd announced that its Board of Directors has recommended a final dividend of ₹0.40 per equity share for the financial year ended March 31, 2026. This recommendation is subject to shareholder approval at the 38th Annual General Meeting scheduled for September 23, 2026. The company has fixed September 16, 2026, as the record date for determining dividend entitlement. The dividend payment, if approved, will be made after September 23, 2026, with applicable TDS deductions. The filing also details TDS provisions for resident and non-resident shareholders, including rates and documentation requirements for exemptions.
Key Highlights
- Board recommends final dividend of ₹0.40 per share for FY26.
- Dividend subject to shareholder approval at AGM on September 23, 2026.
- Record date for dividend entitlement set as September 16, 2026.
- TDS applicable on dividend payment as per Income-tax Act, 2025.
- Details provided on TDS rates and exemption procedures for shareholders.
Price Impact
More from SMSPHARMA